Zui (???) is a Board Certified Psychiatrist of Japan, who is interested in two major research topics. First, Zui is eager to understand how brain stimulation techniques (e.g., TMS, DBS, and tDCS) might improve the functions and symptoms in psychiatric disorders. Second, Zui wishes to know how biological outcomes such as brain images may predict the onset and severity of mental disorders, in the context of biomarkers for these conditions. Thus, his postgraduate training has laid the foundation for these goals. During his time in Japan, Zui conducted clinical trials that examined the effect of tDCS in patients with schizophrenia. In these trials, he found that the neural activity as measured by NIRS at baseline predicts the treatment effect of tDCS in this condition. After coming to the US, he learned advanced statistical methods in the Johns Hopkins Bloomberg School of Public Health. Zui joined the Brain Stimulation Lab in 2020 and is currently engaged in clinical trials for depression/OCD/bipolar disorder.

Honors & Awards

  • Research Colloquium for Junior Investigators, American Psychiatric Association (2019)
  • Travel Fellowship Award, Johns Hopkins Bloomberg School of Public Health (2019)

Boards, Advisory Committees, Professional Organizations

  • Member, American Psychiatric Association (2019 - Present)

Professional Education

  • Doctor of Medicine, Kyoto University (2012)
  • Doctor of Philosophy, National Center of Neurology and Psychiatry Partner Graduate School (University of Yamanashi) (2018)
  • Master of Health and Science, Johns Hopkins University (2019)

Stanford Advisors

Footer Links:

Stanford Medicine Resources: